Metsera, Inc (NASDAQ:MTSR) IPO will take place January, 31 on the NASDAQ exchange under the ticker MTSR.
The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on July 30, 2025.
See also: Benzinga IPO Calendar
About Metsera, Inc
Metsera, Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
